Artificial intelligence (AI) has significant potential to improve the monitoring of patients with non-Hodgkin’s lymphoma (NHL) by enabling more precise, timely, and personalized care. NHL is a complex group of blood cancers affecting the lymphatic system, and managing it requires…
Big data plays a transformative role in improving clinical outcomes for patients with non-Hodgkin’s lymphoma (NHL) by enabling more precise diagnosis, risk stratification, treatment monitoring, and personalized therapy decisions. The integration of large-scale data sets from genomic sequencing, circulating tumor…
Non-Hodgkin’s lymphoma (NHL) is a complex group of blood cancers that originate in the lymphatic system, primarily affecting B cells or T cells. One of the most intriguing and challenging aspects of NHL research is understanding how these cancer cells…
Designing safer CAR-T cell therapies for non-Hodgkin’s lymphoma (NHL) involves a multifaceted approach that addresses the unique challenges of efficacy, toxicity, and tumor environment complexity. Researchers focus on engineering CAR-T cells to maximize their cancer-fighting abilities while minimizing harmful side…
Precision immunotherapy holds significant promise for improving outcomes in patients with relapsed non-Hodgkin’s lymphoma (NHL) by tailoring treatments to the unique characteristics of each patient’s cancer and immune system. Unlike traditional therapies that broadly target rapidly dividing cells, precision immunotherapy…
Vaccines play a growing and important role in preventing relapse of non-Hodgkin’s lymphoma (NHL), a type of blood cancer that affects lymphocytes, which are a key part of the immune system. The role of vaccines in this context is multifaceted,…
Non-Hodgkin’s lymphoma (NHL) treatments can indeed accelerate cognitive decline in some patients, primarily due to the neurotoxic effects of therapies such as chemotherapy, radiation, and immunotherapy. This cognitive decline often manifests as difficulties with memory, attention, processing speed, and executive…
Non-Hodgkin’s lymphoma (NHL) can affect long-term brain health in several complex and interconnected ways, especially when the lymphoma involves the central nervous system (CNS) directly or indirectly. The impact on brain health arises from the disease itself, its spread to…
Non-Hodgkin’s lymphoma (NHL) is a complex blood cancer affecting the lymphatic system, and its treatment often imposes a heavy financial burden on patients and their families. Research into NHL holds significant promise not only for improving health outcomes but also…
The quality of survivorship research plays a **crucial role in the care of patients with non-Hodgkin’s lymphoma (NHL)** by shaping how long-term outcomes, quality of life, and symptom management are understood and addressed throughout and after treatment. Survivorship research focuses…